Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Piportil Depot 50mg/1ml solution for injection ampoules (JHC Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Robinul 200micrograms/1ml solution for injection ampoules (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clexane 40mg/0.4ml solution for injection pre-filled syringes (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Enoxaparin sodium 20mg/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clexane 20mg/0.2ml solution for injection pre-filled syringes (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Sustanon 100 solution for injection 1ml ampoules 6 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sustanon 100 solution for injection 1ml ampoules (Organon Laboratories Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dalteparin sodium 12,500units/0.5ml solution for injection pre-filled syringes 5 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fragmin 12,500units/0.5ml solution for injection pre-filled syringes (Pfizer Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dalteparin sodium 2,500units/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fragmin 2,500units/0.2ml solution for injection pre-filled syringes (Pfizer Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules 25 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cidomycin 80mg/2ml solution for injection ampoules (Sanofi) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genticin Injectable 80mg/2ml solution for injection ampoules (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Efcortesol 100mg/1ml solution for injection ampoules (Sovereign Medical) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/20ml (0.5%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Xylocaine 0.5% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 2ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 2ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 2ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 2ml ampoules (The Boots Company) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 2ml ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 2ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Octreotide 1mg/5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Phytomenadione 1mg/0.5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Konakion Neonatal 1mg/0.5ml solution for injection ampoules (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 10mg/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 10mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 10mg/5ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nandrolone 50mg/1ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Deca-Durabolin 50mg/1ml solution for injection ampoules (Organon Laboratories Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 10mg/5ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hypnovel 10mg/5ml solution for injection ampoules (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclizine tartrate 50mg/1ml / Morphine tartrate 15mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclimorph 15 solution for injection 1ml ampoules (CeNeS Pharmaceuticals) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclizine tartrate 50mg/1ml / Morphine tartrate 10mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cyclimorph 10 solution for injection 1ml ampoules (CeNeS Pharmaceuticals) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium chloride 0.9% solution for injection 500ml polyethylene bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Polyfusor S sodium chloride 0.9% solution for injection 500ml bottles (Fresenius Kabi Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium chloride 0.9% solution for injection 1litre polyethylene bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Polyfusor S sodium chloride 0.9% solution for injection 1litre bottles (Fresenius Kabi Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcitonin (salmon) 100units/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Miacalcic 100units/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calsynar 100units/1ml solution for injection ampoules (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 3,500units/0.35ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Innohep 3,500units/0.35ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 10,000units/0.5ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 10,000units/0.5ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Innohep 10,000units/0.5ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 14,000units/0.7ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 14,000units/0.7ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Innohep 14,000units/0.7ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 18,000units/0.9ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 18,000units/0.9ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Innohep 18,000units/0.9ml solution for injection pre-filled syringes (LEO Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lorazepam 4mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ativan 4mg/1ml solution for injection ampoules (Wyeth Laboratories) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Salbutamol 500micrograms/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ventolin 500micrograms/1ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glyceryl trinitrate 50mg/50ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nitronal 50mg/50ml solution for infusion vials (Beaumont Pharma Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haloperidol 20mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Serenace 20mg/2ml solution for injection ampoules (IVAX Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nitrocine 50mg/50ml solution for injection vials (Schwarz Pharma Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glyceryl trinitrate 5mg/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nitronal 5mg/5ml solution for infusion ampoules (Beaumont Pharma Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Buserelin 5.5mg/5.5ml solution for injection vials 2 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Suprefact 5.5mg/5.5ml solution for injection vials (Neon Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Suprecur 5.5mg/5.5ml solution for injection vials (Neon Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Betamethasone 4mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Betnesol 4mg/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline hydrochloride 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Acetylcysteine 2g/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet adrenaline 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes 21 gauge (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Parvolex 2g/10ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet adrenaline 1mg/1ml (1 in 1,000) solution for injection pre-filled syringes 25 gauge (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Certoparin sodium 3,000units/0.3ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alphaparin 3,000units/0.3ml solution for injection pre-filled syringes (Grifols UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 500micrograms/0.5ml (1 in 1,000) solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 600micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|